Global Contraceptives Market is expected to reach $15.6 billion by 2023 - Allergan, Bayer, Merck & Co., Teva Pharmaceutical

Global Contraceptives Market-Drivers, Restraints, Opportunities, Trends, and Forecasts: 2017-2023
Overview: Birth control has a broad positive impact and has expanded opportunities for women in terms of economic advancements, educational attainment, and improved health outcomes. A contraceptive helps individuals and couples to gain basic right and is a right to decide when and how many children to have. The rising adoption of traditional and modern methods of contraception has resulted in the improvement not only in health-related outcomes but in several economic and social issues. For instance, it has reduced the infant mortality and maternal mortality rates. According to Centers for Disease Control and Prevention (CDC), the introduction toward access to modern contraceptives is among one of the 10 great public health achievements of the 20th century.

Sample Copy Available at https://www.reportsweb.com/inquiry&RW00011868227/sample

The implementation of modern contraceptive methods offers safe provision by eliminating unwanted restrictive practices and medical barriers. The WHO has developed a set of medical eligibility criteria that is based on a collaborative review of all clinical, research, epidemiological, and modern contraceptive methods.
The major products in the market include:
-Yasmin and Yaz (oral pills)
-NuvaRing (Vaginal Ring)
-Milex Wide Seal (Diaphragm)
-Mirena and ParaGard (IUDs)
-Ortho Evra (or Evra patch)
-Implanon (implant)

The market is dominated by Allergan Plc, Bayer AG, Merck & Co., Teva Pharmaceutical, and Church & Dwight, which has more than 65% to 75% market share in the Global Contraceptives Market. Factors, such as an increase in the incidence of unwanted pregnancies, rise in the adoption of oral pills and its advantages over other contraceptives, the unmet need for contraception in developing countries, growing awareness and initiatives taken by governments to prevent unwanted pregnancies, are expected to boost the market growth.

Market Analysis: The Global Contraceptives Market is estimated to witness a CAGR of 4.3% during the forecast period 2017-2023. The market is analyzed based on three segments, namely product type, end-users, and regions.

The government in most of the developing countries are taking initiatives for creating awareness about contraceptives by conducting programs and collaborating with NGOs to have an effective spread of contraceptives in order to reduce poverty and illiteracy caused due to unplanned births. It is encouraging the use of condoms by supplying them door to door and imparting knowledge to prevent the spread of STDs and restrict population growth. However, few rural areas, and cultural and religious opposition in certain emerging countries, such as China, India, Thailand, Vietnam, Malaysia, and Philippines, hinder the market growth.

Product Analysis: Contraceptive drugs are growing at a moderate rate and dominates the global contraceptives market with 62% of the total market share. Factors, such as rise in prevalence of unwanted pregnancies, rise in adoption of oral pills and its advantages over other contraceptives, and government initiatives, are driving the market growth. Contraceptive drugs are most frequently used for birth control and is widely adopted among young couples and career-oriented professional women. Contraceptive devices play an important role in saving individuals from getting STDs, preventing unwanted pregnancies, and help in family planning. The contraceptive devices market is estimated to be $10.5 billion in 2016 and is expected to reach $15.6 billion by 2023, growing at a CAGR of 5.7% during the forecast period, 2016-2023.

Key Players: Allergan Plc, Bayer AG, Merck & Co., Teva Pharmaceutical, Church & Dwight, and other predominant & niche players.

Competitive Analysis: The global contraceptives market has immense growth opportunities for vendors in both developed and developing regions. The market in the developed countries is seeing an increase in the adoption of modern contraceptives, especially in the US, Canada, France, Germany, the UK, and few of the Middle East countries. These countries have the highest number of frequent user population accounting to 70% to 75% of the total contraceptive population worldwide.

Place Direct Purchase Order Here: https://www.reportsweb.com/buy&RW00011868227/buy/2750

Table of Contents:

1 Industry Outlook 9

2 Report Outline 16

3 Market Snapshot 18

4 Market Outlook 21

5 Market Segmentation by Product Types: Market
Size & Analysis 32

6 Regions: Market Size & Analysis 45

7 Competitive Landscape 53
8 Vendor Profiles 55
8.1.1 Allergan plc 55
8.1.1.1 Overview 55
8.1.1.2 Business unit 58
8.1.1.3 Business focus 59
8.1.1.4 SWOT analysis 59
8.1.1.5 Business strategies 60
8.1.2 Bayer AG 61
8.1.2.1 Overview 61
8.1.2.2 Business unit 63
8.1.2.3 Business focus 64
8.1.2.4 SWOT analysis 65
8.1.2.5 Business strategies 66
8.1.3 Merck & Co., Inc. 66
8.1.3.1 Overview 66
8.1.3.2 Business unit 68
8.1.3.3 Business focus 69
8.1.3.4 SWOT analysis 69
8.1.3.5 Business strategies 71
8.1.4 Teva Pharmaceutical Industries Ltd 71
8.1.4.1 Overview 71
8.1.4.2 Business unit 74
8.1.4.3 Business focus 75
8.1.4.4 SWOT analysis 75
8.1.4.5 Business strategies 76
8.1.5 Church & Dwight 77
8.1.5.1 Overview 77
8.1.5.2 Business unit 78
8.1.5.3 Business focus 79
8.1.5.4 SWOT analysis 79
8.1.5.5 Business strategies 80

For more information about this report: https://www.reportsweb.com/reports/Global-Contraceptives-Market-Drivers-Opportunities-Trends-and-Forecast-2017-2023

Contact Info:
Name: Sameer
Email: sales@reportsweb.com
Organization: ReportsWeb
Phone: +1-646-491-9876

Pune, India

ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.

This release was published on openPR.